|
Market Closed -
Nasdaq
04:00:00 07/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 402.60 USD | -0.09% |
|
-3.71% | +23.00% |
| 10-03 | AbbVie joins US government pilot to test drug discount rebates | RE |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 218B 193B 181B 164B 310B 21,002B 312B 2,174B 845B 10,714B 818B 800B 34,443B | P/E 2026 * |
25.5x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 259B 230B 215B 195B 369B 25,001B 371B 2,588B 1,006B 12,754B 973B 953B 41,001B | EV / Sales 2026 * |
6.66x | EV / Sales 2027 * | 6.29x |
| Free-Float |
99.77% | Yield 2026 * |
2.5% | Yield 2027 * | 2.64% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Tradegate
| AMG | Real-time | |
|
Boerse Muenchen
| AMG | Real-time | |
|
London S.E.
| 0R0T | Delayed | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
CBOE
| Real-time | ||
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Börse Stuttgart
| AMG | Delayed | |
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote | |
|
CBOE
| 0R0T | Real-time |
Last Transcript: Amgen Inc.
| 1 day | -0.09% | ||
| 1 week | -3.71% | ||
| Current month | -4.49% | ||
| 1 month | -7.92% | ||
| 3 months | +7.60% | ||
| 6 months | +15.71% | ||
| Current year | +23.00% |
| 1 week | 396.01 |  | 426.59 |
| 1 month | 374.46 | | 426.59 |
| Current year | 318.21 | | 447.03 |
| 1 year | 288 | | 447.03 |
| 3 years | 249.7 | | 447.03 |
| 5 years | 198.64 | | 447.03 |
| 10 years | 133.64 | | 447.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/9/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 13/8/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 7/8/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.09% | -3.71% | +35.15% | +51.88% | 218B | |
| +1.26% | -2.30% | +37.82% | +113.76% | 1,019B | |
| +0.73% | -6.31% | +35.06% | +62.14% | 610B | |
| +0.35% | +0.15% | +14.01% | +80.87% | 470B | |
| +1.72% | -4.54% | +59.14% | +37.01% | 344B | |
| +0.26% | -1.58% | +21.97% | +41.79% | 336B | |
| +0.60% | -3.48% | +11.37% | +34.33% | 266B | |
| +1.65% | -4.27% | -5.47% | +9.69% | 241B | |
| -0.28% | -5.24% | +27.99% | +93.08% | 179B | |
| -0.51% | -2.66% | -35.19% | -61.38% | 164B | |
| Average | +0.54% | -3.57% | +20.19% | +46.32% | 384.66B | |
| Weighted average by Cap. | +0.80% | -3.49% | +26.74% | +64.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.94B 34.57B 32.35B 29.32B 55.37B 3,754B 55.77B 388B 151B 1,915B 146B 143B 6,156B | 40.31B 35.78B 33.49B 30.35B 57.32B 3,886B 57.74B 402B 156B 1,982B 151B 148B 6,373B |
| Net income | 8.58B 7.62B 7.13B 6.46B 12.2B 827B 12.29B 85.61B 33.3B 422B 32.21B 31.52B 1,357B | 9.39B 8.34B 7.8B 7.07B 13.36B 905B 13.45B 93.72B 36.45B 462B 35.26B 34.5B 1,485B |
| Net Debt | 41.49B 36.83B 34.46B 31.24B 58.99B 3,999B 59.42B 414B 161B 2,040B 156B 152B 6,559B | 35.82B 31.79B 29.75B 26.97B 50.93B 3,453B 51.3B 357B 139B 1,761B 134B 132B 5,662B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | US$402.60 | -0.09% | 2,036,227 |
| 05/10/26 | US$402.98 | -0.01% | 3,104,125 |
| 02/10/26 | US$403.04 | -1.04% | 3,510,312 |
| 01/10/26 | US$407.27 | -3.38% | 2,501,030 |
| 30/09/26 | US$421.51 | -0.50% | 3,130,965 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
